DXCM Q2 2021 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$26B

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$595M+31.7% YoY

Gross Profit

$417M70.1% margin

Operating Income

$101M17.0% margin

Net Income

$63M10.6% margin

EPS (Diluted)

$0.19

QoQ Revenue Growth

+17.8%

Cash Flow

Operating Cash Flow

$62M

Free Cash Flow

-$40M

Stock-Based Comp.

$32M

Balance Sheet

Total Assets

$4.5B

Total Liabilities

$2.5B

Stockholders' Equity

$2.0B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$595M	$452M	+31.7%
Gross Profit	$417M	$284M	+46.8%
Operating Income	$101M	$68M	+49.0%
Net Income	$63M	$46M	+35.9%

Geographic Segments

UNITED STATES

$462M78%

Non-US

$134M22%